Molecule Details
InChIKeyUFPFGVNKHCLJJO-SSKFGXFMSA-N
Compound NameLcl-161
Canonical SMILESCN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Homologous
Avg pChEMBL7.71
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB12085
Drug NameLCL-161
CAS Number1005342-46-0
Groups investigational
ATC Codes nan
DescriptionLCL161 has been used in trials studying the treatment of Leukemia, Neoplasms, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others.

Categories: Antineoplastic Agents Proto-Oncogene Proteins c-bcl-2, antagonists & inhibitors Sulfur Compounds
Cross-references: BindingDB: 50441356 CHEMBL2431768 ChemSpider: 30687709 PDB: IUN PubChem:24737642 PubChem:347828391 ZINC: ZINC000095929260
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
Q96CA5 BIRC7 Homo sapiens Human PF00653 PF13920 7.9 IC50 ChEMBL;BindingDB
Q13489 BIRC3 Homo sapiens Human PF00653 PF00619 PF21290 PF13920 7.8 IC50 ChEMBL;BindingDB
Q13490 BIRC2 Homo sapiens Human PF00653 PF00619 PF21290 PF13920 7.7 IC50 ChEMBL;BindingDB
P98170 XIAP Homo sapiens Human PF00653 PF21290 PF13920 7.4 IC50 ChEMBL;BindingDB
DrugBank Target Actions (6)
Target Gene Target Name Action Type
O15392 O15392 Baculoviral IAP repeat-containing protein 5 modulator targets
P98170 XIAP E3 ubiquitin-protein ligase XIAP modulator targets
Q13075 Q13075 Baculoviral IAP repeat-containing protein 1 modulator targets
Q13489 BIRC3 Baculoviral IAP repeat-containing protein 3 modulator targets
Q13490 BIRC2 Baculoviral IAP repeat-containing protein 2 modulator targets
Q96CA5 BIRC7 Baculoviral IAP repeat-containing protein 7 modulator targets